Calendar of Events

Registering for NMD will help you to:

Join Biogen, Acceleron Pharma, Roche, Voyager and more at NMD this October - don’t miss this opportunity to unite with like-minded peers to overcome your roadblocks preventing you developing truly transformative neuromuscular treatments.

- Address pharma-physician disconnect in Europe with the EMA
- Understand considerations from European Health Technology Assessment Bodies when assessing the value of medicines for NASH with NICE
- Review regulatory guidance for NASH with compensated cirrhosis with the FDA

Join 80+ other NASH drug developers to navigate solutions for these and 10+ other rate limiting factors as the first NASH therapies receive approval.

Venue Details: The Waldorf Hilton, London, Aldwych, London, WC2B 4DD, United Kingdom

Date and Time: On Wednesday October 23, 2019 at 9:00 am ends Friday October 25, 2019 at 4:30 pm

Over 40 presentations, case studies and panel discussions focusing on the key issues in cell line optimisation, 3D cell culture and bioprocessing technologies

Cell Line Development
PART 1: Early Cell Culture and Cell Line Engineering
PART 2: 3D Cell Culture Models and Applications
Process Development: Upstream Bioprocessing and Analytics
Cell Line Development: Late Stage Cell Line Development, Stability, Data and Assay Data Development
Cell Culture and Downstream Bioprocessing
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

NCAC SOT 2019 Fall Symposium: Toxicology and Safety Considerations in the Development of Devices and Drugs
Thursday, October 24, 2019
NIH Campus, Bethesda, MD

The inaugural Inflammasome Therapeutics Summit (ITS) is industry's first dedicated discussion and networking forum focused on bringing together inflammasome thought-leaders to share the latest scientific progress and address the current challenges drug developers are facing. With the mission to bridge the gap between research and drug development and develop clinically effective candidates for inflammatory driven diseases.

Developed in combination with experts from Nodthera, Pfizer and IFM Therapeutics and other leading organisations, this industry focused forum allows you to determine which diseases the inflammasome is driving and therefore which have the most therapeutic potential commercially and clinically, review the basic biology and mechanisms of action and the use of biomarkers and endpoints for increased efficacy in clinical trials to name a few.

MSBSS Paper of the Year Award
Dr. Maria Monteiro, Harvard Medical School
A High-Throughput Screen Identifies DYRK1A Inhibitor ID-8 That Stimulates Human Kidney Tubular Epithelial Cell Proliferation

MSBSS Graduate Student Research Award
Dr. Kari Neier, University of Michigan
Reprogramming of Peroxisome Proliferator-Activated Receptor Target Genes in Mice Perinatally Exposed to Phthalates

Salient Features:
Keynote Speech of Toxicology Experts
50+ plenary talks by researchers all over the globe
Opportunity to meet global experts in Environmental Toxicology
Impressive Exhibitions
Posters, e-posters and video presentation by research community
International Certification by Organizing Committee
Live Streaming of your presentation through our websites and YouTube
Publishing accepted abstract in International Journals

USEFUL LINKS:

https://bit.ly/2YaxEtd prev conf agenda

Understanding risk assessment is one thing. Communicating about risk is another. The Society of Toxicology of Canada is partnering with experts for an interactive, hands-on workshop that will boost your skills in both areas.

• Stay on top of the science.

• Gain a deeper understanding of risk assessment methods.

• Maximize the value of toxicology studies in characterizing risk.

• Encourage the use of sound science in risk-based decision-making.

• Apply practical tools for communicating your work.

Green Acre Campus Pointe
10300 Campus Point Dr, San Diego, CA 92121

We will have over 600 end users representing internationally renowned research And academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.

Discussion Workshop and Breakfast: 10x Genomics Platform, Technologies Overview and Updates on The Human Cell Atlas Project.

Healthcare focus: benchmarking RNA Seq sequencing technologies in the clinic, biopsies and single cell analyses to improve stratification of patient and diagnosis.

We will have over 600 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.

Including 2 interactive streams:

Over two days delegates have the opportunity to debate on burning issues in the industry, learn from top executives and visionaries who are driving the industry, and network with key decision makers for future business opportunities and collaboration.

For sponsorship / exhibition enquiries, please contact Joe Hames via email: joe.hames@ft.com

Vascular Biology 2019 focuses on entailing several interactive scientific sessions. It also offers an enthusiastic opportunity for the growing generations occupied in various researches to improve their abilities in the field.

For sponsorship/exhibition opportunities please get in touch. Contact data as well as the sponsorship brochure can be found on www.mrna-conference.com.

However, despite the rise in new products and services that claim to target the microbiome and improve health across adult and infant populations, there are fundamental questions surrounding the functional, clinical and practical applicability of microbiome-directed research that currently remains unresolved.

Group discounts, start-up and early booking rates are available. Please visit the website for full pricing information.

The 25th annual BIO-Europe event is the largest biotechnology partnering conference held in Europe. Over 4,350 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward.
BIO-Europe's world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business.

Venue Details: Hamburg Messe, Messeplatz 1, Hamburg, 20357, Germany

Date and Time: On Monday November 11, 2019 at 7:00 am ends Wednesday November 13, 2019 at 6:00 pm

we take great pride in our highly reputed global event welcoming all the attendees for our International Conference on Parkinson’s and Movement Disorder at London, UK on November 11-12, 2019. This conference will deliver new ideas, convictions, strategies and tactics where no conference will offer an impressive roaster of Keynote speakers, quality attendees, and compelling content. The various thematic sessions will be discussed at this conference, we welcome all of you to attend the conference.

“35th World Vaccines and Immunization Congress” mainly focuses on the gathering and concentrate on the trending advances and development in every aspect of Vaccines and Immunization research which takes an opportunity in meeting, organizing and see the new logical advancements of the specialists and researchers. We foresee a great scientific faculty from Australia and in addition from different nations with some highly interesting scientific researchers to delegate the occasion. We unconditionally invite all the prominent, Professors, Students and delegates to participate in this upcoming Vaccines and Immunization event to witness a valuable scientific occasion and to participate in Vaccines Workshop, Vaccines Symposium & contribute to the future innovations in the field of Vaccines & Immunization.

Venue: - Four points by Sheraton Brisbane, 99 Mary street, Brisbane city, Queensland, Australia

- Discover the Importance of Gathering Real World Evidence for Development and Launch of New Complement Therapeutics
- Modulate the Alternative Pathway with a Diverse Pipeline of Targets and Modalities
- Hear Clinical Trial Experience to Accelerate your Complement Therapeutics Through the Clinic
- Discover How to Create Translatable Complement Assays
- Improve Translational Biomarker

Attend this meeting to gain clear clinical understanding of the potential role of complement in common indications and identify which indication will be the next big opportunity for complement-based therapeutics.

The 40th Annual Meeting will be at the JW Marriott Desert Ridge in Phoenix, Arizona in 2019.

The Annual Meeting is the heart and soul of the College, a venue for discussing emerging trends in the field of toxicology, networking with friends and colleagues, and professional development. The program is designed by and for members with the goal of providing excellent quality scientific and regulatory content that is directly applicable to the practice of toxicology. The American College of Toxicology is a professional society of a size and culture ideal for scientists of all career stages seeking continuing education, novel and new ideas and strategies, and personal interactions with speakers, other members and guests, and exhibitors.

The 40th Annual Meeting will include a wide-ranging scientific program, a 40th Annual Meeting opening presentation followed by a welcome reception and dinner, the popular traditional poster session reception, awards ceremony and luncheon, distinguished plenary speakers, and networking events. The ACT Annual Meeting offers a unique opportunity for toxicologists preparing for the challenges and decisions that will affect public health and safety in years to come.

The speaker has worked on numerous design development projects in Class II and Class III medical devices as well as establishing Quality Management Systems which include easy-to-understand methods to meet design development and design control requirements. This webinar will walk you through step-by-step how to complete a DIOM for your product and simplify this often overly complex process.

Why should you Attend
Better understanding of FDA regulations with regards to design input and output
An organized approach in meeting design input and output requirements
A simplified way to ensure design inputs and outputs are continually maintained and tracked
Areas Covered in the Session
Introduction to the DIOM template
How to identify your design inputs
How to categorize your design inputs and their sources
Ways in which design inputs can be verified
Common documents and activities used as design output evidence
Additional requirements of design inputs and outputs
Who Will Benefit
Quality Assurance
Regulatory Affairs
Design Engineers
Manufacturing Engineers
Startup Companies

Speaker Profile
Denise Wrestler ASQ CQE, CQA; QA/RA Consultant at CYA Medical Device Consulting, LLC with almost 15 years of experience within FDA-regulated industries including medical device and pharmaceuticals, Ms. Wrestler provides quality, regulatory, and technical expertise to meet individual client needs. Ms. Wrestler agrees with the FDA's "least burdensome approach" and prides herself on providing options and recommendations for ensuring regulations are met without wasting precious company resources.

The medical device industry across the US and Europe is in flux. Are you prepared? Join us at MedTech Summit US on November 18 - 20, 2019 in Chicago, IL. We will bring together industry, Notified Body experts and key stakeholders from across the US and from the EU to share the very latest on EU MDR implementation, FDA and software regulations, as well as a pre-conference workshop focused on Medical Device Regulatory Project Management. This dedicated US event will be your opportunity to take away the latest regulatory developments, share insight from industry experts and gather knowledge from leading authorities.

On Monday November 18, 2019 at 8:00 am (ends Wednesday November 20, 2019 at 5:00 pm)

Venue details:
Renaissance Chicago Downtown Hotel, 1 West Wacker Drive, Chicago, 60601, United States

Price:
2 Day Conference Pass: USD 1595.0

ExL’s Pain Management Summit, created based off the former annual Human Abuse Liability Summit, will serve as a platform for professionals in the pain industry to discuss the latest trends in analgesic developments, including the newest progress in abuse-resistant technologies, cannabinoids and marijuana for pain management and treatment of abuse disorders, non-opioid pain drugs, and other therapeutics. It will also explore other issues contributing to the ongoing opioid crisis, including opioid guideline myths, inappropriate treatment approaches, and the transition from oxycodone overdoses to fentanyl and heroin overdoses.

In addition, this forum speaks to the similarities and differences between research collaborations and IITs, including responsibilities; ownership of the research, royalties and publication rights; and, most crucially, when it’s viable and appropriate to support each type of collaboration.

Probiotics-2019 mainly showcases comprehensive approaches in research and usage of probiotics. This Conference revolves around the novel discovery and development. The conference includes Keynote lectures by eminent personalities from around the world in addition to contributed papers both oral and poster presentations.

Please mail us at: probiotics@madridge.com
Submit your abstracts at: https://probiotics.madridge.com/abstract-submission
Registration site: https://probiotics.madridge.com/register

For the 2nd year, network with the KOLs and RNA pioneers, to gain a comprehensive understanding on how to translate the first generation of RNA targeted small molecules into the clinic, stimulate the discussion of successfully targeting RNA via interfering with RNA-protein interactions and seize the therapeutic opportunity in hand by re-defining the undruggable nature of RNA.

Pharma Meeting & Expo 2019 focuses on Drug Discovery & Designing, Drug Delivery Research and Technologies, Pharmacovigilance, Pharmaceutics and Pharmacokinetics, Pharma Market Research, Pharmaceutical Manufacturing and many more. Meet your target market with individuals from around the globe concentrated on finding out about Pharma, this is your single best chance to achieve the biggest array of members in our Pharma conference.

Optimizing testing strategies and exploring novel mechanisms of human and environmental toxicants

Humans are exposed to thousands of chemical substances; however, only a few of them have been assessed for their effects on human health and on the environment. There is an urgent need to develop new methods and strategies to more rapidly and efficiently predict the effects of those substances. In this vein, the overall aim of this meeting is to present and discuss new scientific technologies and alternative approaches to evaluating mechanisms of toxicology. This meeting will enable researchers from government, academia and industry, that are engaged in toxicology research and safety assessment, to discuss how we can contribute to the development and adoption of these new technologies. It is hoped that attendees can utilize and/or further develop these strategies to optimize their own research or work practices such that data generated is more predictive of risks to human health or to environmental health. This meeting also provides opportunities for toxicology trainees to present their research, either orally or by poster, and network with a variety of individuals from government, academia, and industry. This platform and intimate setting of the meeting allows toxicologists to share ideas and foster collaboration, and improve the science of toxicology, which supports the SOT mission of creating a safer and healthier world.

Over 3 days packed with compelling case studies, diverse panels and varied networking opportunities, you'll glean insights from industry and academic leaders. The 2019 agenda will reflect the strides taken by the community over the past year as well as forming the future of oncolytic virus development.

Our conversations have highlighted that there are critical areas of basic science that need addressing including demonstrating the causality of microbiome gut-brain interactions, translating microbiome science into therapeutic or nutritional targets through pre-clinical models and harnessing clinical experience to inform in-human study design to accelerate product development.

Group discounts, start-up, academic and early booking rates are available. Please visit the website for full pricing information.

The 8th annual PREDiCT: Tumour Models London will return this December with a fresh speaker faculty to help you benchmark your oncology model selection strategy and target validation. With the rise of immuno-oncology, model requirements, target validation and the importance of tumour micro-environment are key to clinical success. The 3-days summit will provide you with real world data from a selected model experts, including Merck Healthcare KGaA, MedImmune, Kymab, Leiden University, Basilea Pharmaceutica for practical insights.

Join this community to meet 100+ like-minded translational, in vivo and pharmacology scientists to discuss how to enhance predictiveness and translatability of your preclinical models.

Venue Details: DoubleTree by Hilton Hotel London - Tower of London, 7 Pepys Street, London, EC3N 4AF, United Kingdom

Date and Time: On Wednesday December 04, 2019 at 9:00 am ends Friday December 06, 2019 at 5:00 pm

This year's trailblazing keynotes include:
- Janine Schuurman, Ph.D., Vice President, Research, Genmab
- George Georgiou, Ph.D., Professor, Laura Jennings Turner Chair in Engineering, The University of Texas at Austin
- Gary Nabel, M.D., Ph.D., Chief Scientific Officer and Senior Vice President, Head, North America R&D Hub, Sanofi
- Marjolein van Egmond, Ph.D., Professor of Oncology and Inflammation, Amsterdam University Medical Center

- Review recent gene therapy clinical successes and failures targeting neurological disorders to identify improvement areas and opportunities to guide your future research
- Discover the latest advances in administration routes and vector engineering to improve delivery success
- Address immunogenicity and the dosage challenges seen with gene therapies to identify the optimal therapeutic window

- Increased perspective from CROs
- Representation from regulatory authorities
- Functional implementation of TMF systems
- Risk-based monitoring and processes
- Exploring functional areas and their teams
- Innovations and advancements in technology
- Collaboration with clinical sites

Venue Details: Sheraton Orlando Lake Buena Vista Resort, 12205 South Apopka Vineland Road, Orlando, 32836, United States

Date and Time: On Tuesday January 21, 2020 at 9:00 am ends Thursday January 23, 2020 at 5:00 pm

Top Five Reasons to Attend:
*To assess REMS efficacy with proven methods from industry professionals
*Complying with regulations pertaining to standardization and evaluation
*Collaborate with industry leaders on innovative approaches for REMS design, implementation, and solutions
*Increase knowledge and awareness of upcoming REMS technologies, innovation and regulatory changes
*Discussing the challenges of recent FDA guidelines impacting REMS

REMS
Risk Management
Pharmacovigilance/Surveillance
Quality Assurance
Drug/Product Safety
Clinical Risk Management
Lifecycle Management
Regulatory Affairs/Legal/Compliance
Clinical Affairs
Clinical Data Management
Clinical Operations
Clinical Risk Management Compliance
Epidemiology/Pharmacoepidemiology
Marketing

Registration is required.

Four years in the drug development world isn’t long, and the progress made in continuous processing has been an extraordinary. Thanks to the encouragement of the FDA and maturing technology; both pharma and biotech are starting to adopt continuous manufacturing (CM) in a commercial setting.

At the 4th Annual CCP Summit we will continue to explore scientific and technology advancements that can help eliminate bottlenecks, and more importantly, will address the quality, upfront investment and business rationale behind the ‘switch’.

It takes immense pleasure to invite you to attend 4th International Conference on Chronic Diseases (Chronic Diseases 2020) scheduled to be held in Paris, France during February 17-18, 2020.
Chronic Diseases 2020 is a global event focusing on the immense knowledge and major advances in the rapidly emerging fields of chronic diseases by attracting experts and professionals across the universe.

Visit: https://chronicdiseases.cmesociety.com/

Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers for in vitro applications patient-derived tissues, drug discovery, predictivity and validation, and safety and toxicity.

Bioprinting has become increasingly efficient and accurate in building in vitro tissue models with the potential to provide pathologically relevant responses and model human disease mechanisms. Bio-printed structures yield phenotypic endpoints that are comparable with clinical studies and can provide a realistic prediction of clinical efficacy. The use of bioprinting is growing in big pharma companies as an alternative to organ-on-a-chip systems.

WHO SHOULD ATTEND?
Biotech / Pharma Companies - Team Leader, Junior Principle investigator, Cell and Molecular Scientist, Chief Scientific Officer, Deputy Director, Manager, Founder, CEO, Head, Director, Programme Manager, Lab Head, Toxicologist
Academia Professor - Cell Technology, Stem Cell Sciences, Biochemistry, Protein Technology and Tissue Engineering
Solution Providers – Manager, Head of, CEO, Director, Founder, Account Manager, President, CSO, Executive, Managing Director

Oxford Global is proud to present for the 15th year our flagship Biomarkers Series UK, 18 – 20 February 2020, Manchester, UK. This year promises to be the most exciting Biomarkers Series to date, with a host of new features alongside the popular programme to ensure you gain vital updates on the latest biomarker initiatives and technologies.

Featuring the following interactive streams:

New for 2020, we are pleased to announce the following features:

- The Inaugural Genomic Markers Congress: Two dedicated streams on the integration of genomic markers into drug development to enable precision medicine
- A pre-event focus day: Deep-dive sessions in the morning to provide insights into key therapeutic areas from leading experts and end-user workshops in the afternoon to showcase key platforms to incorporate in your workflow. Spaces are limited, so sign-up early to avoid disappointment
- Our Day 1 workshop on Biomarker Qualification: Technical Validation and Regulatory Aspects
- Our Day 2 workshops on Data Analysis and Bioinformatics and Genomic Biobanking to Facilitate Precision Medicine

On Tuesday February 18, 2020 at 7:00 am (ends Thursday February 20, 2020 at 7:00 pm)

Registration is required.

For Registration: http://stemcell.alliedacademies.com/registration

Contact Details:

Leon Bezos,
Program Director,
Stem Cell 2020,
E: stemcellcongress@geneconferences.com
Tel: (+44) 2037691755
What's App: (+44) 1403582077

7 Conference Session Themes:
- Novel Engineering and Discovery Strategies
- ADCs/Antibody-Drug Conjugates
- Bispecific Antibodies and Multi-Functional Biologics
- Immuno-Oncology
- Preclinical and Clinical Case Studies
- Delivery Strategies and Crossing/Penetrating Biological Barriers
- Engineering Strategies for TCR and CAR T Cell Therapies

Target Audience:

• Academic, industry and government researchers engaged in developing therapeutic approaches and medical countermeasures (MCMs) against ocular pathologies resulting from exposure to chemical toxicants
• Government stakeholders and funding agencies

Objectives of the Scientific Meeting:

• Development of MCMs that mitigate acute and chronic corneal manifestations in response to ocular toxicants relies on the development of well-characterized experimental models with defined pathophysiology that allow for effective bridging to humans. Such models are also essential to demonstrate therapeutic efficacy.
• This meeting will bring together subject matter experts from the civilian and military research communities to discuss the current state of the field, including potential therapeutic approaches and available models.
• Attendees of the workshop will contribute to our understanding of pathologies and models available for studying toxic ocular injuries and their utility in the research and development of therapeutics. Most importantly, the workshop will address current knowledge gaps to identify possible refinements or new directions to advance MCM development.

Session Topics:

• Acute and Chronic Responses to Corneal Toxicity
• Mechanistic Basis of Corneal Pathophysiologies and Wound Healing
• Therapeutically Accessible Models of Corneal Toxic Injury
• Therapeutic Approaches to Mitigate Corneal Pathophysiologies
• Current Research/Development Perspectives and Resources for Researchers
• Meeting Wrap Up

Organizers:

• National Eye Institute (HHS/NIH/NEI)
• U.S. Army Medical Research Institute for Chemical Defense (DoD/USAMRICD)
• National Institute of Allergy and Infectious Diseases (HHS/NIH/NIAID)

Opportunities for travel awards, oral and/or poster presentations are available - see

Uniting the leading minds from large pharma, biotech and academia, this summit will help you advance novel target site discovery, improve drug-like properties and accelerate the translation of potent and mutation-specific RAS targeted therapeutic strategies into human clinical trials. With numerous approaches emerging that demonstrate genuinely viable efficacy in targeting the RAS family of proteins, join the RAS- Targeted Drug Discovery Summit Europe to gain first-hand insights on the challenges and strategies to robustly translate promising anti-RAS therapies into the clinic.

At this event, we intend to provide a platform to share the recent developments in Pharmaceutical Industry and promote collaborations between the brands and Institutions. With the presence of renowned speakers from various parts of the globe sharing their expertise in vast areas of the Pharmaceutical sciences, we hope the attendees would have a great knowledge sharing sessions at the conference.

Obesity-2020 conference includes Plenary lectures, Keynote lectures and short courses by eminent personalities from around the world in addition to contributed papers both oral and poster presentations.

The theme of the Conference is “Science and education for action against HPV”. Through workshops, lectures, oral and poster sessions presenting the latest research results, the program will cover papillomavirus (PV)-related topics from basic science to global health impact. We will be paying special attention to HPV prevention and control in populations that are most vulnerable to HPV disease worldwide, including those in Low- and Middle-Income Countries.

Our overarching theme will be harnessing the power of innovation from HPV research to deliver global prevention and control of HPV-related disease.

See you at IPVC 2020!

Join 2000+ pharma decision-makers and healthcare innovators to:

Why you need to attend:

-9 dedicated conference streams: Barcelona is huge – 2000+ people in total. Yet it’s also intimate, tailored just for you. You’ll spend most of the conference in one of 9 tracks with sessions that hit all your buttons.
- All stakeholders. All functions. 1 place: The most cross-functional pharma event in the world – executives from marketing, commercial, sales, market access, medical affairs, patient engagement, RWE, IT, clinical and more.
- More than just conference sessions: Sometimes, the best ideas don’t come from the stage. They come from those chance happenings when you joined a roundtable or went to a networking evening.

Venue Details: Centre de Convencions Internacional de Barcelona, 11-14 Plaça de Willy Brandt, Barcelona, 08019, Spain

Once again, the conference will bring together the leading microbiome companies working to successfully commercialize microbiome-based diagnostics, therapeutics, adjunct therapies and direct-to-consumer services and products across a range of therapeutic areas, from gut to skin and beyond. Expanding on this core focus year on year, we continue to offer informative, hands-on workshops, panels sponsored and directed by industry to focus on your concerns and tightly curated content that goes beyond the usual infomercials to provide tangible and useful insights to how your peers are addressing their commercial approach to the space.

The unique scientific program of the Congress will bring you the latest updates in the field of autoimmune diseases, presented by the world's leading experts, while at the same time providing an amazing stage for young upcoming talents to present their research to a first-rate audience.

Established by Professor Yehuda Shoenfeld, the congress constitutes a network of international leaders on immunology, rheumatology and related fields, all of whom contribute their unique and diverse knowledge to the "family of autoimmunity."

SLAS Europe 2020 provides a unique combination of education, access to innovative technologies and intelligent peer networking, delivering unmatched value for professionals and students looking to discover the latest life sciences technologies and how they can be applied to drive research objectives.

This year, the symposium will be held on the Penn State University campus in State College, PA from June 14-18, 2020. The sessions will showcase cutting edge research and highlight advancements in the study of AHR in terms of public and environmental health, toxicology, pharmacology and biology of development. The themes of the symposium will therefore address many systems / models of pathologies related to environmental toxicology.

Along with opportunities to network with colleagues from around the world and learn the latest scientific information, the Penn State campus and surrounding area offers many things to do and see. Central Pennsylvania is a beautiful part of the United States boasting scenic mountains, local culture, and a world class research institution. Come for the meeting, but make sure to take advantage of all the area has to offer.